Gabather AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gabather AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8127
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidates in form of small molecules that integrate with the Gaba receptor complex in the brain. The company targets diseases include learning, cognition, sleep regulation, pain, anxiety, epilepsy, muscular tension and addiction, among others. It serves in the US, Canada, China and India. Gabather is headquartered in Malmo, Sweden.

Gabather AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Equity Offering 12
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB – Key Competitors 16
Gabather AB – Key Employees 17
Gabather AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Gabather AB, Pharmaceuticals & Healthcare, Key Facts 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB, Key Competitors 16
Gabather AB, Key Employees 17

List of Figures
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gabather AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析
    Summary St. Jude Children’s Research Hospital Inc (St. Jude) is a healthcare service provider that offers research and clinical care services for children with catastrophic diseases. The hospital provides treatment programs such as brain tumors, leukemia, infectious diseases, immunodeficiency diseas …
  • TUV Nord AG:企業の戦略的SWOT分析
    TUV Nord AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Mednax Inc (MD)-製薬・医療分野:企業M&A・提携分析
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • Wind Direct Ltd:電力:M&Aディール及び事業提携情報
    Summary Wind Direct Ltd (Wind Direct) a subsidiary of Infinite Renewables Ltd is a renewable energy company that installs and operates industrial wind turbines. The company’s services include feasibility studies, wind turbine installation, and operation services. It offers consulting services to che …
  • Mitsubishi Electric Corp (6503):企業の財務・戦略的SWOT分析
    Mitsubishi Electric Corp (6503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Trimble Inc (TRMB):企業の財務・戦略的SWOT分析
    Trimble Inc (TRMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Liechtensteinische Landesbank Private Clients:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mylan NV (MYL):製薬・医療:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • OUE Ltd:企業の戦略・SWOT・財務情報
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Weyerhaeuser Co (WY):企業の財務・戦略的SWOT分析
    Weyerhaeuser Co (WY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aero-Tech Engineering, Inc.:企業の戦略・SWOT・財務情報
    Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rhenovia Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rhenovia Pharma Ltd (Rhenovia) is a biotechnology company that provides solutions for the treatment of Alzheimers disease and other central nervous system diseases. The company offers studies to academic research groups and industries based on biosimulation technology, which is a computation …
  • Florida Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Florida Power & Light Company (FPL), a subsidiary of NextEra Energy, Inc., is a vertically-integrated electric utility that generates, transmits and distributes electricity. The company generates electricity from oil, natural gas, coal, nuclear and solar sources. It also purchases power and …
  • Neviot Nature of Galilee Ltd.:企業の戦略・SWOT・財務分析
    Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report Summary Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Navios Maritime Partners L.P.:企業のM&A・事業提携・投資動向
    Navios Maritime Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Rothschild Bank Ag
    Rothschild Bank Ag - Strategy, SWOT and Corporate Finance Report Summary Rothschild Bank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CorEnergy Infrastructure Trust Inc (CORR):企業の財務・戦略的SWOT分析
    CorEnergy Infrastructure Trust Inc (CORR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆